Candidate drugs against SARS-CoV-2 and COVID-19Article Published on 2020-04-292023-07-01 Journal: Pharmacological research [Category] SARS, [키워드] Arbidol camostat Chloroquine COVID-19 drugs Favipiravir Lopinavir phytochemicals Remdesivir Ritonavir SARS-CoV-2 [DOI] 10.1016/j.phrs.2020.104859 PMC 바로가기 [Article Type] Article
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling StudyArticle Published on 2020-04-232022-10-30 Journal: Marine Drugs [Category] COVID-19, SARS, [키워드] acute respiratory syndrome Antiviral approach approaches caused Consensus coronavirus COVID-19 docking drugs Effectiveness global public health highlight HIV protease inhibitor inhibitor inhibitors involved library lifecycle likelihood Lopinavir M pro marine natural product MERS middle MNP modeling molecular molecular docking molecular dynamics natural outbreak pharmacological target product protease Protein provide SARS-CoV SARS-CoV-2 screened Screening Spread syndrome these compound Treatment Virtual screening [DOI] 10.3390/md18040225 PMC 바로가기 [Article Type] Article
[What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]Article Published on 2020-04-122023-07-14 Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese [Category] SARS, [키워드] 2019-nCoV Chloroquine Coronavirus disease 2019 immune response Lopinavir SARS-CoV Viral load [DOI] 10.3760/cma.j.cn112147-20200218-00119
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitroArticle Published on 2020-04-032023-07-02 Journal: Antiviral Research [Category] SARS, [키워드] Abstract COVID-19 Emetine homoharringtonine Lopinavir Remdesivir Ritonavir [DOI] 10.1016/j.antiviral.2020.104786 PMC 바로가기 [Article Type] Article
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatmentCase Reports Published on 2020-03-162023-07-13 Journal: Bioscience trends [Category] SARS, [키워드] 2019-nCoV Arbidol Lopinavir Ritonavir Shufeng Jiedu capsule [DOI] 10.5582/bst.2020.01030 [Article Type] Case Reports
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment optionReview Published on 2020-03-122022-10-04 Journal: Journal of medical virology [Category] MERS, SARS, 비임상, [키워드] acute respiratory syndrome antiviral therapy caused coronavirus COVID‐19 COVID‐19 effective Efficacy Epidemics in vitro in vivo inhibit inhibiting Lopinavir LPV MERS MERS patients Middle East outbreak outcome Panic Patient patients with SARS potential treatment option Protease activity public health SARS SARS Coronavirus syndrome systematic review therapy Treatment were used Wuhan [DOI] 10.1002/jmv.25729 PMC 바로가기 [Article Type] Review
Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, ChinaArticle Published on 2020-01-012023-07-05 Journal: Journal of Zhejiang University. Science. B [Category] SARS, [키워드] darunavir lipid metabolism Lopinavir Pneumonia SARS-CoV [DOI] 10.1631/jzus.B2000204 PMC 바로가기
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New CoronavirusArticle Published on 2020-01-012023-07-05 Journal: Current medicinal chemistry [Category] SARS, [키워드] antiviral drugs coronavirus COVID-19 Favipiravir Hydroxychloroquine Lopinavir Remdesivir Ritonavir SARS-CoV-2 [DOI] 10.2174/0929867327666200416131117
[Adverse effects of lopinavir/ritonavir in critically ill patients with COVID-19]Article Published on 2020-01-012023-07-05 Journal: Medicina [Category] SARS, [키워드] Argentina COVID-19 Critical care Lopinavir Ritonavir
Broad-spectrum coronavirus antiviral drug discoveryReview Published on 2019-03-082023-06-14 Journal: Expert opinion on drug discovery [Category] MERS, SARS, [키워드] acute respiratory distress syndrome Antiviral ARDS bat broad-spectrum Camel Civet coronavirus emerging virus highly pathogenic virus human cases in vitro model interferon Lopinavir MERS MERS-CoV Middle East respiratory syndrome Pneumonia primate model respiratory ribavirin Rodent model SARS SARS-CoV Severe acute respiratory syndrome therapeutic zoonosis zoonotic [DOI] 10.1080/17460441.2019.1581171 PMC 바로가기 [Article Type] Review